Small Pharma (DMTTF) Stock Price, News & Analysis

Company Overview

Small Pharma Inc. was a United Kingdom-based biotechnology company focused on developing psychedelic-assisted therapies for mental health conditions. Its research centered on dimethyltryptamine (DMT), a short-acting psychedelic compound, with the goal of creating treatments that could be administered alongside psychological support.

The company’s development pipeline included SPL026, an investigational DMT-based therapy studied for major depressive disorder, as well as SPL028, an earlier-stage program based on a next-generation DMT compound. Small Pharma also worked on drug formulations and treatment protocols intended to support the clinical use of psychedelic medicines.

Founded in 2015 and headquartered in London, Small Pharma conducted research and clinical development activities in the United Kingdom and other jurisdictions through its clinical programs. In 2023, Cybin Inc. completed its acquisition of Small Pharma, bringing the company’s assets and operations into Cybin’s psychedelic therapeutics business. Small Pharma’s shares, including those previously quoted under the OTCMKTS symbol DMTTF, are therefore associated with its former status as an independent company.

Key Stats

• Today's Range: $0.11 to $0.11
• 50-Day Range: $0.11 to $0.11
• 52-Week Range: $0.05 to $0.19
• Volume: N/A
• Average Volume: 113,204 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:DMTTF
• CIK: N/A
• Web: www.smallpharma.co.uk
• Phone: N/A
• Fax: N/A
• Employees: 13
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A